News

The trial will assess the safety, tolerability and pharmacokinetics of SGN-70 in healthy volunteers. The Phase I study is a dose-escalation trial in which cohorts of healthy volunteers

In connection with a decision made by DelSite’s board of directors, DelSite will exit the wound care business, including the manufacture of wound care products under the Carrington

The company has filed its abbreviated new drug application (ANDA) containing a paragraph IV certification for a generic Xyzal product with the FDA in January 2008. Following receipt

Lupin’s divalproex sodium delayed-release tablets are the AB-rated generic equivalent of Abbott Laboratories’s Depakote tablets, indicated for the treatment of certain types of seizures and convulsions. It may

The Phase I-II study is a multicenter, open-label study of the X-linked inhibitor of apoptosis antisense AEG35156 in patients with relapsed or refractory chronic lymphocytic leukemia (CLL), small

Intraoperative neurophysiological monitoring services (IONM) assesses neurological function involving the brain, spinal cord and related nerve structures during such surgeries. Acording to Impulse Monitoring, use of IONM facilitates

The units were priced at $0.70 per unit which at closing separated into a share of PolyMedix common stock and a five year warrant to purchase a share

The new supply agreement relates to Dyloject, Javelin’s proprietary injectable diclofenac product currently marketed in the UK and in the second of two pivotal trials in the US,

Cardinal Health will also offer Prime Therapeutics additional supply chain optimization services to help improve its operational efficiency. Mike Kaufmann, group president of healthcare supply chain services –